Molecular Therapeutics Program

Share

Researchers at the Brain Tumor Center Molecular Therapeutics Program seek to understand the biological mechanisms of cancer’s spread to the brain and to develop effective new ways to treat the condition.

The program was established with a $2 million gift from the Harold C. Schott Foundation and $4.5 million in additional funds from the UC College of Medicine and its Departments of Neurosurgery and Radiation Oncology and the Division of Hematology-Oncology.

The program is building a translational research and patient care program that is interdisciplinary and dedicated exclusively to tackling the growing problem of brain metastasis.

The Molecular Therapeutics Program, believed to be the first translational, metastasis-specific program of its kind in the United States, is a collaboration between the UC Gardner Neuroscience Institute and the UC Cancer Institute. It will allow UC to build a subspecialized research team that will collaborate with the existing brain tumor clinicians and surgeons to address the problem of brain metastases through translational research and original clinical trials.

Researchers seek a better understanding of how and why cancers metastasize to the brain in order to develop specific therapies to treat existing brain metastases and possibly prevent their formation.

Related articles

UC Brain Tumor Molecular Therapeutics Program Launched >>

Schott Foundation Helps Put a Bull’s-Eye on Metastatic Brain Tumors >>

Focus on Faculty with Atsuo Sasaki, PhD >>

The Sasaki Laboratory >>

 

 

  • Print This Page
  • Make an Appointment: Schedule Now
  • Sign up for our newsletter!
  • UCNI Weekly Blog
  • Hope Stories

    • Dick’s Story: Memory

      Dick's Story: MemoryDick was enjoying his retirement as a full-time volunteer at Crayons to Computers when his memory began to go awry. He told his granddaughter that his car was due for an oil change, when he had just had the oil...
    • Lynne’s Story

      Lynne's StorySemiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Jim’s Story: Pituitary Tumor

      Jim's Story: Pituitary Tumor One turn of events led to another, and so it was that Jim, and not his wife, took Jim’s 87-year-old father to his appointment with the dermatologist for the first time. And so it was that the dermatologist was not...
    • Jerry’s Story: Spinal Tumor

      Jerry's Story: Spinal Tumor On an ordinary day in February 2009, John M. Tew, MD, got one of the true surprises of his career. He was seeing patients in his Mayfield Clinic office on the University of Cincinnati medical campus when an unexpected guest...
    • Brian’s Story: Meningioma

      Brian's Story: Meningioma “Carefree” is the word Brian uses to describe his life back then. He was 39 years old, happily married and the father of three children under the age of 5. “Life was busy, but that felt normal,” he says, reflecting. “The only...
    • Lynne’s Story: Brain Metastasis

      Lynne's Story: Brain MetastasisSemiretired and working part-time at a restaurant, Lynne knew something was amiss when she looked at the cash register and then struggled to make her hands produce the correct amount of change. Could she have suffered a stroke? Lynne pushed the...
    • Bob’s Story: Recurrent Glioblastoma

      Bob's Story: Recurrent Glioblastoma Glioblastomas come back. Sometimes sooner, sometimes later, but they always come back. “That’s the...
    • Blake’s Story: Medulloblastoma

      Blake's Story: Medulloblastoma Blake knew he was in the right hands the moment he saw the surgeon’s wrists. Dr. John M. Tew, Blake’s neurosurgeon, was wearing one of Lance Armstrong’s yellow LiveStrong cancer bracelets. So was Blake. Dr. Tew, who was also sporting...